People · Operator
Named in public records as an officer, director or promoter · active 2009–2021 · Healthtech, Pharmaceuticals, Robotics, Manufacturing / Industrial, Other Technology, Software / Tech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Healthcare, Inc. | — | Healthtech | Series D+ | $246.8M | $4.0B | 2021 |
| Trevena Inc | — | Pharmaceuticals | Series C | $77.5M | $2.1B | 2013 |
| Faction Holdings, Inc. | — | Robotics | Series B | $72.0M | $119.0M | 2012 |
| Sapient Industries, Inc. | — | Manufacturing / Industrial | Series B | $21.2M | $193.3M | 2019 |
| Ip Commerce Inc | — | Other Technology | Series A | $13.4M | $99.5M | 2009 |
| EdgeConneX, Inc. | — | Other Technology | Series A | $6.5M | $69.4M | 2011 |
| Digital Fortress Holdings, Inc. | — | Software / Tech | Seed | $5.4M | $85.2M | 2013 |
| Lightspeed Technologies Inc | — | Other Technology | Pre-Seed | $430K | $18.2M | 2009 |
David Solomon at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Solomon on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Derek Pilling | 3 | 5 |
| Mark Hughes | 2 | 5 |
| Gordon Cohen | 2 | 2 |
| William Marraccini | 2 | 2 |
| David Johnson | 1 | 35 |
| John Burke | 1 | 14 |
| James Pastoriza | 1 | 9 |
| David Zilberman | 1 | 8 |
| Robert Garland | 1 | 7 |
| Michael Schwartz | 1 | 7 |
| David Blundin | 1 | 7 |
| Mark Reed | 1 | 6 |
| Christopher Mirabelli | 1 | 6 |
| Stephen Martin | 1 | 5 |
| Francis Knuettel II | 1 | 5 |
| Farah Champsi | 1 | 5 |
| Jose Vargas | 1 | 5 |
| Sarah Kim | 1 | 4 |
| Mark Ashida | 1 | 4 |
| Ralph Snyderman | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.